Quantcast
Last updated on April 18, 2014 at 13:02 EDT

Latest Circulating Tumor Cell Stories

New Microdevice Enables Culture Of Rare Circulating Tumor Cells From Blood
2012-04-24 13:31:25

Ability to culture rare tumor cells isolated from blood could help improve patient response to therapy A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children´s Hospital Boston has created a microfluidic device that can harvest rare circulating tumor cells (CTCs) from blood to enable their expansion in culture for analysis. These cells, which have detached from a primary cancer site and often create a secondary --...

2012-04-23 06:27:46

RARITAN, N.J., April 23, 2012 /PRNewswire/ -- Veridex, LLC announced today that it has joined with Novartis Pharmaceuticals Corporation in an educational alliance to encourage and facilitate research involving circulating tumor cells, or CTCs, as a potential biomarker in metastatic prostate cancer. As part of this initiative, Veridex will support a prospective, single arm, open-label study designed to investigate the effect of zoledronic acid* on CTCs in patients with metastatic...

2012-04-02 10:24:58

HOUSTON, April 2, 2012 /PRNewswire/ -- Scientists at ApoCell, Inc., in partnership with researchers at Virginia Commonwealth University (VCU) Massey Cancer Center, have used the company's revolutionary ApoStream(TM) technology for a new first ---the reliable isolation and recovery of circulating tumor cells (CTCs) from patients with hepatocellular carcinoma (HCC), one of the most common forms of liver cancer. Globally, liver cancer is the third most common cause of cancer-related deaths....

2012-04-02 06:27:40

CHICAGO, April 2, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results of three preclinical studies focused on c-MET, a receptor tyrosine kinase that, when it functions normally, plays a key role in transmitting signals within a cell. Abnormalities in c-MET function and signaling have been found in many types of cancer including lung, breast, prostate, gastric, esophageal and renal cancers. Two of the abstracts (#2734 and #2738) assess the anti-cancer activity of...

2012-03-26 13:24:56

Scientists are enlisting the living, self-propelled microbes found in pond scum – the pea-green surface slicks that form on ponds – in the development of a long-awaited new test to detect the cells that spread cancer through the bloodstream from the original tumor to new sites in the body. In a report here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, they described how the test is intended...

2012-03-26 06:29:47

SINGAPORE, March 26, 2012 /PRNewswire-Asia/ -- Clearbridge BioMedics has achieved ISO13485 certification for the development of cell-based in-vitro diagnostic devices and today launched its revolutionary ClearCell(TM) System, for the cancer research market. This is one of the world's first commercially-available systems that can successfully isolate circulating tumour cells (CTC) from blood, using biomechanical properties. The ClearCell(TM) System, which consists of the proprietary...

2012-03-22 10:58:11

Detecting the presence of circulating tumor cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the disease. CTCs are cancer cells which are detectable in patients with a solid tumor and their value in the prognosis of metastatic breast cancer has been known for a few years. Until now, however, there has been little information about their role in early disease....

2012-02-08 03:30:00

ALBANY, New York, February 8, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012 [http://www.researchmoz.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-report-2012-report.html ] This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields. In this report, we...

2012-02-02 18:00:40

Series of 5 studies highlights potential of technology to boost patient care, research Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs)–breakaway cells from patients' solid tumors–from cancer patients. The findings, reported in five new papers, show that the highly sensitive blood analysis...